Filing Details
- Accession Number:
- 0001209191-18-064322
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-28 16:34:59
- Reporting Period:
- 2018-12-26
- Accepted Time:
- 2018-12-28 16:34:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1674416 | Crispr Therapeutics Ag | CRSP | Pharmaceutical Preparations (2834) | MA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | 50 Northern Avenue Boston MA 02210 | No | No | Yes | No | |
| 1761216 | Ltd (Europe) Pharmaceuticals Vertex | 2 Kingdom St., 9Th Floor London X0 W2 6BD | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2018-12-26 | 12,737 | $24.89 | 5,353,479 | No | 4 | P | Direct | |
| Common Shares | Acquisiton | 2018-12-27 | 27,461 | $24.95 | 5,380,940 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Shares are directly held by Vertex Pharmaceuticals (Europe) Limited ("Vertex Europe"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe.
- Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.69 and $25.00.
- Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.85 and $25.00.
Billionaire Hedge Funds
